Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in J Clin Gastroenterol

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    June 2017
  1. SOKOLLIK C, Fournier N, Rizzuti D, Braegger CP, et al
    The Use of 5-Aminosalicylic Acid in Children and Adolescents With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2017 Jun 21. doi: 10.1097/MCG.0000000000000864.
    PubMed     Text format     Abstract available


    May 2017
  2. FERREIRO-IGLESIAS R, Barreiro-de Acosta M, Dominguez-Munoz JE
    Reply to: Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients.
    J Clin Gastroenterol. 2017 May 17. doi: 10.1097/MCG.0000000000000839.
    PubMed     Text format    


    April 2017
  3. CLICK B, Anderson AM, Ramos Rivers C, Koutroubakis IE, et al
    Telephone Encounters Predict Future High Financial Expenditures in Inflammatory Bowel Disease Patients: A 3-Year Prospective Observational Study.
    J Clin Gastroenterol. 2017 Apr 27. doi: 10.1097/MCG.0000000000000801.
    PubMed     Text format     Abstract available


    March 2017
  4. MCCURDY JD, Bruining DH, Loftus EV Jr
    Potential Pitfalls When Assessing the Impact of Cytomegalovirus in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2017 Mar 8. doi: 10.1097/MCG.0000000000000812.
    PubMed     Text format    


    February 2017
  5. DAI C, Cao Q, Jiang M
    Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients.
    J Clin Gastroenterol. 2017 Feb 2. doi: 10.1097/MCG.0000000000000807.
    PubMed     Text format    


    January 2017
  6. RINAWI F, Assa A, Hartman C, Mozer Glassberg Y, et al
    Long-term Extent Change of Pediatric-Onset Ulcerative Colitis.
    J Clin Gastroenterol. 2017 Jan 6. doi: 10.1097/MCG.0000000000000741.
    PubMed     Text format     Abstract available


    December 2016
  7. SUSKIND DL, Cohen SA, Brittnacher MJ, Wahbeh G, et al
    Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2016 Dec 27. doi: 10.1097/MCG.0000000000000772.
    PubMed     Text format     Abstract available


  8. SHAH SC, Naymagon S, Cohen BL, Sands BE, et al
    There is Significant Practice Pattern Variability in the Management of the Hospitalized Ulcerative Colitis Patient at a Tertiary Care and IBD Referral Center.
    J Clin Gastroenterol. 2016 Dec 22. doi: 10.1097/MCG.0000000000000779.
    PubMed     Text format     Abstract available


  9. DU L, Foshaug R, Huang VW, Kroeker KI, et al
    Within-Stool and Within-Day Sample Variability of Fecal Calprotectin in Patients With Inflammatory Bowel Disease: A Prospective Observational Study.
    J Clin Gastroenterol. 2016 Dec 22. doi: 10.1097/MCG.0000000000000776.
    PubMed     Text format     Abstract available


  10. FERREIRO-IGLESIAS R, Barreiro-de Acosta M, Lorenzo-Gonzalez A, Dominguez-Munoz JE, et al
    Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance With Anti-TNF Therapy: A Prospective Longitudinal Cohort Study.
    J Clin Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  11. SHUKLA T, Singh S, Tandon P, McCurdy JD, et al
    Corticosteroids and Thiopurines, But Not Tumor Necrosis Factor Antagonists, are Associated With Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    J Clin Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  12. WANG Y, Aggarwal P, Liu X, Lu H, et al
    Antiviral Treatment for Colonic Cytomegalovirus Infection in Ulcerative Colitis Patients Significantly Improved Their Surgery Free Survival.
    J Clin Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  13. STRISCIUGLIO C, Bellini G, Miele E, Martinelli M, et al
    Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  14. GROSSBERG LB, Ezaz G, Grunwald D, Cohen J, et al
    A National Survey of the Prevalence and Impact of Cytomegalovirus Infection Among Hospitalized Patients With Ulcerative Colitis.
    J Clin Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  15. BERNSTEIN CN, Eliakim A, Fedail S, Fried M, et al
    World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015.
    J Clin Gastroenterol. 2016;50:803-818.
    PubMed     Text format    


    October 2016
  16. TSEN A, Alishahi Y, Rosenkranz L
    Autoimmune Pancreatitis and Inflammatory Bowel Disease: An Updated Review.
    J Clin Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  17. HASHASH JG, Ramos-Rivers C, Youk A, Chiu WK, et al
    Quality of Sleep and Coexistent Psychopathology Have Significant Impact on Fatigue Burden in Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  18. CASSIERI C, Pica R, Avallone EV, Zippi M, et al
    Prevalence of Colonic Diverticulosis in Patients Affected by Ulcerative Colitis: A Prospective Study.
    J Clin Gastroenterol. 2016;50 Suppl 1:S33-5.
    PubMed     Text format     Abstract available


    September 2016
  19. CORICA D, Romano C
    Biological Therapy in Pediatric Inflammatory Bowel Disease: A Systematic Review.
    J Clin Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  20. GU P, Theiss A, Han J, Feagins LA, et al
    Increased Cell Adhesion Molecules, PECAM-1, ICAM-3, or VCAM-1, Predict Increased Risk for Flare in Patients With Quiescent Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  21. CARVALHANA S, Goncalves A, Velosa J
    Cutaneous Pseudolymphoma in a Patient With Crohn's Disease Under Infliximab: First Report.
    J Clin Gastroenterol. 2016;50:436-7.
    PubMed     Text format    


    April 2016
  22. SAYAR E, Yucel A, Eisele B, Sayar EH, et al
    The Ineffectiveness of Tacrolimus in an Infant With a Mutation in the IL-10 Receptor.
    J Clin Gastroenterol. 2016;50:352-3.
    PubMed     Text format    


  23. FERGES W, Rampertab SD, Shafqet M, Salimi Q, et al
    Experience With Anti-TNF-alpha Biologic Agents in Succession in Patients With Crohn's Disease: A Retrospective Analysis of a Single Center.
    J Clin Gastroenterol. 2016;50:326-30.
    PubMed     Text format     Abstract available


    March 2016
  24. PUGA M, Carpio D, Sampil M, Zamora MJ, et al
    Ocular Toxoplasmosis Reactivation in a Patient With Inflammatory Bowel Disease Under Treatment With Azathioprine.
    J Clin Gastroenterol. 2016.
    PubMed     Text format    


    February 2016
  25. BURR NE, Hull MA, Subramanian V
    Folic Acid Supplementation May Reduce Colorectal Cancer Risk in Patients With Inflammatory Bowel Disease : A Systematic Review and Meta-Analysis.
    J Clin Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  26. ABREU C, Carvalho T, Sarmento A, Magro F, et al
    Stool Isolation of Nocardia nova in Two Immunomodulated Patients With Inflammatory Bowel Diseases.
    J Clin Gastroenterol. 2016;50:92.
    PubMed     Text format    


    November 2015
  27. KORELITZ BI
    Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbation of Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2015.
    PubMed     Text format    


  28. CHIBBAR R, Dieleman LA
    Probiotics in the Management of Ulcerative Colitis.
    J Clin Gastroenterol. 2015;49 Suppl 1.
    PubMed     Text format     Abstract available


  29. KIM A
    Dysbiosis: A Review Highlighting Obesity and Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2015;49 Suppl 1.
    PubMed     Text format     Abstract available


    October 2015
  30. BARNES EL, Allegretti JR
    Are Anti-Tumor Necrosis Factor Trough Levels Predictive of Mucosal Healing in Patients With Inflammatory Bowel Disease?: A Systematic Review and Meta-Analysis.
    J Clin Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  31. TAE CH, Jung SA, Moon HS, Seo JA, et al
    Importance of Patients' Knowledge of Their Prescribed Medication in Improving Treatment Adherence in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  32. DAI C, Jiang M, Sun MJ
    The Impact of Smoking on Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2015.
    PubMed     Text format    


  33. LONG MD, Kappelman MD, Martin CF, Chen W, et al
    Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  34. KOUTROUBAKIS IE, Ramos-Rivers C, Regueiro M, Koutroumpakis E, et al
    Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort.
    J Clin Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  35. GORDON GL, Zakko S, Murthy U, Sedghi S, et al
    Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical Trial.
    J Clin Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  36. DEFONSEKA AM, Tuskey A, Conaway MR, Behm BW, et al
    Antitumor Necrosis Factor-alpha Therapy is Associated With Reduced Risk of Thromboembolic Events in Hospitalized Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  37. DUCHARME-BENARD S, Cote-Daigneault J, Lemoyne M, Orlicka K, et al
    Patients With Inflammatory Bowel Disease are Unaware of the Impact of Smoking on Their Disease.
    J Clin Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  38. STEIN BN, Pellish RS, Thompson KD, Baptista V, et al
    Using Therapeutic Drug Monitoring to Identify Variable Infliximab Metabolism in an Individual Patient With Ulcerative Colitis.
    J Clin Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  39. STEENHOLDT C, Frederiksen MT, Bendtzen K, Ainsworth MA, et al
    Time Course and Clinical Implications of Development of Antibodies Against Adalimumab in Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  40. WANGENSTEEN KJ, Fogt F, Kann BR, Osterman MT, et al
    Idiopathic Myointimal Hyperplasia of the Mesenteric Veins Diagnosed Preoperatively.
    J Clin Gastroenterol. 2015;49:491-4.
    PubMed     Text format     Abstract available


    June 2015
  41. ANDERSON B, Sweetser S
    Menetrier Disease and Ulcerative Colitis.
    J Clin Gastroenterol. 2015.
    PubMed     Text format    


    May 2015
  42. CHRISTOPHI GP, Ciorba MA
    Lower Dose Infliximab for Ulcerative Colitis: How Low Can We Go and How Much Can be Saved?
    J Clin Gastroenterol. 2015.
    PubMed     Text format    


  43. DAI C, Jiang M, Sun MJ
    Fecal Calprotectin as a Predictor of Relapse in Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2015.
    PubMed     Text format    


    April 2015
  44. TURSI A, Inchingolo CD, Picchio M, Elisei W, et al
    Histopathology of segmental colitis associated with diverticulosis resembles inflammatory bowel diseases.
    J Clin Gastroenterol. 2015;49:350-1.
    PubMed     Text format    


    March 2015
  45. ALLI-AKINTADE L, Pruthvi P, Hadi N, Sachar D, et al
    Race and fistulizing perianal Crohn's disease.
    J Clin Gastroenterol. 2015;49:e21-3.
    PubMed     Text format     Abstract available


    February 2015
  46. PARK SK, Ye BD, Lee C, Im JP, et al
    Risk and clinical characteristics of lymphoma in Korean patients with inflammatory bowel diseases: a multicenter study.
    J Clin Gastroenterol. 2015;49:e11-6.
    PubMed     Text format     Abstract available


  47. KOTZE PG, Spinelli A
    Adalimumab for perianal fistulizing Crohn's disease: real-world data adds important information for clinical practice.
    J Clin Gastroenterol. 2015;49:174-5.
    PubMed     Text format    


    January 2015
  48. CASTANO-MILLA C, Chaparro M, Saro C, Barreiro-de Acosta M, et al
    Effectiveness of adalimumab in perianal fistulas in crohn's disease patients naive to anti-TNF therapy.
    J Clin Gastroenterol. 2015;49:34-40.
    PubMed     Text format     Abstract available


  49. MARKAR SR, Wiggins T, Kumar S, Hanna GB, et al
    Exhaled breath analysis for the diagnosis and assessment of endoluminal gastrointestinal diseases.
    J Clin Gastroenterol. 2015;49:1-8.
    PubMed     Text format     Abstract available


    October 2014
  50. HU D, Ren J, Wang G, Li G, et al
    Exclusive enteral nutritional therapy can relieve inflammatory bowel stricture in Crohn's disease.
    J Clin Gastroenterol. 2014;48:790-5.
    PubMed     Text format     Abstract available


    September 2014
  51. ZHANG W, Zhu W, Li Y, Zuo L, et al
    The respective role of medical and surgical therapy for enterovesical fistula in Crohn's disease.
    J Clin Gastroenterol. 2014;48:708-11.
    PubMed     Text format     Abstract available


  52. PARK SK, Kim KJ, Lee SO, Yang DH, et al
    Ciprofloxacin usage and bacterial resistance patterns in Crohn's disease patients with abscesses.
    J Clin Gastroenterol. 2014;48:703-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: